Polish Journal of Pathology
eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2025
vol. 76
 
Share:
Share:
Case report

Diagnostic challenge of primary colonic poorly cohesive adenocarcinoma exhibiting gastric‑type immunohistochemistry profile and focal signet‑ring differentiation

Gizem Issın
1
,
Merve Tok
2
,
Diren Vuslat Çağatay
3
,
Oruç Numan Gökçe
3
,
Faruk Önder Aytekin
3

  1. Department of Pathology, Faculty of Medicine, Canakkale Onsekiz Mart University, Faculty Çanakkale, Turkey
  2. Department of General Surgery, Faculty of Medicine, Canakkale Onsekiz Mart University, Çanakkale, Turkey
  3. Department of Pathology, Gumushane State Hospital, Gumushane, Turkey
Pol J Pathol 2025; 76 (4): 348-354
Online publish date: 2026/02/16
Article file
- Diagnostic challenge.pdf  [4.96 MB]
Get citation
 
PlumX metrics:
 
1. Makhdoomi RH, Khurshid SU, Shah M. Pathology in colorectal malignancy. New treatment modalities in rectal cancer. In: Parray F, Chowdri N (eds.). Springer, Singapore 2020.
2. Ono Y, Yilmaz O. Emerging and under-recognised patterns of colorectal carcinoma morphologies: a comprehensive review. J Clin Pathol 2024; 77: 439-451.
3. Galanopoulos M, Gkeros F, Liatsos C, Pontas C, Papaefthymiou A, Viazis N et al. Secondary metastatic lesions to colon and rectum. Ann Gastroenterol 2018; 31: 282-287.
4. Kandalaft PL, Gown AM. Practical applications in ımmunohistochemistry: carcinomas of unknown primary site. Arch Pathol Lab Med 2016; 140: 508-523.
5. Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020; 182-188.
6. Gulinac M, Mileva N, Miteva D, Velikova T, Dikov D. Primary signet-ring-cell carcinoma in the colorectum: a case-based lite­rature review. Gastroenterol Insight 2024; 15: 632-646.
7. Stanley RH. World Health Organization Classification of Tumours. pathology and genetics of tumours of the digestive system. Lyon 2000.
8. An Y, Zhou J, Lin G, Wu H, Cong L, Li Y et al. Clinicopathological and molecular characteristics of colorectal signet ring cell carcinoma: a review. Pathol Oncol Res 2021; 27: 1609859.
9. Terada T. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases. Int J Clin Exp Pathol 2013; 6: 703-710.
10. Hrudka J, Matěj R, Nikov A, Tomyak I, Fišerová H, Jelínková K, et al. Loss of SATB2 expression correlates with cytokeratin 7 and PD-L1 tumor cell positivity and aggressiveness in colorectal cancer. Sci Rep 2022; 12: 19152.
11. Zhu X, Bledsoe JR. Frozen section diagnosis of gastrointestinal poorly cohesive and signet-ring cell adenocarcinoma: useful morphologic features to avoid misdiagnosis. Virchows Arch 2020; 477: 497-506.
12. Elnady MS, Eltatawy FA, Nosseir AG, Zamzam YA, El-Guindya DM. Diagnostic accuracy of SATB2 in identifying primary and metastatic colorectal carcinoma: a comparative immunohistochemical study. Ecancermedicalscience 2022; 16: 1491.
13. Gutierrez C, Ogino S, Meyerhardt JA, Iorgulescu JB. The pre- valence and prognosis of microsatellite ınstability-high/ mismatch repair-deficient colorectal adenocarcinomas in the United States. JCO Precis Oncol 2023; 7: e2200179.
14. Alvi MA, Loughrey MB, Dunne P, McQuaid S, Turkington R, Fuchs MA, et al. Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies. Br J Cancer 2017; 117: 203-209.
Copyright: © 2026 Polish Association of Pathologists and the Polish Branch of the International Academy of Pathology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2026 Termedia Sp. z o.o.
Developed by Termedia.